Development and validation of a nomogram to predict recurrence and melanoma ‐specific mortality in patients with negative sentinel lymph nodes

ConclusionA nomogram for predicting recurrence and MSM in patients with melanoma and negative SNs was constructed and validated. It could provide personalized estimates useful for tailoring surveillance strategies (reduce or increase intensity), and selection of patients for adjuvant therapy or clinical trials.

Source: British Journal of Surgery - October 11, 2018 Category: Surgery Authors: D. Verver, D. van Klaveren, V. Franke, A. C. J. van Akkooi, P. Rutkowski, U. Keilholz, A. M. M. Eggermont, T. Nijsten, D. J. Gr ünhagen, C. Verhoef Tags: Original article Source Type: research